Chemotherapy Rechallenge or Reintroduction Compared to Regorafenib or Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: A Propensity Score Analysis of Treatment Beyond Second Line (Proserpyna Study)
| Autor: | Calegari, M.A., Zurlo, I.V., Dell'Aquila, E., Basso, M., Orlandi, A., Bensi, M., Camarda, F., Anghelone, A., Pozzo, C., Sperduti, I., Salvatore, L., Santini, D., Corsi, D.C., Bria, E., Tortora, G. |
|---|---|
| Zdroj: | In Clinical Colorectal Cancer June 2024 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect